ACCOY -001 - Moderate to Severe Pain - Pivotal Trial (Phase IIIa)
ACCOY -002 - Moderate to Severe Pain
ACCOY -003 - Moderate to Severe Pain
ACCOY -004 - Moderate to Severe Pain
* This is not a complete list of ACCOY's pipeline products.
OTHER NOVEL THERAPIES OF INTEREST
Narrow Therapeutic Window Drugs
ACCOY is focused on the development of "Novel New Therapies" that address significant medical needs, prevent dose-mediated adverse events, enable point of care medication and patient management and save money on the total cost of care. ACCOY has identified over 100 drugs, with significant unmet medical needs, for development that historically have been subject to abuse, misuse, addiction, dependence, tolerance, diversion, underdosing, overdosing, under prescribing, over prescribing, have narrow therapeutic windows, or that failed in clinical trials due to safety concerns.
"The products are exciting and potentially game changing for the pain community. "
Lynn Webster, MD
NOVEL CARDIOVASCULAR THERAPIES
ACCOY -006 - Atrial Fibrillation
ACCOY -007 - Antihypertensive
NOVEL IRRITABLE BOWEL SYNDROME THERAPIES
ACCOY -005 - Diarhea Predominant Irritable Bowel Syndrome